BIO 2019 - Tagged with Session Types>Fireside Chats

bio2018-mybio-sessionicon-fireside

113ABC, Level 100

John MaraganoreChief Executive Officer atAlnylam Pharmaceuticals Peter MarksDirector of the Center for Biologics Evaluation and Research (CBER) atFood and Drug Administration Janet WoodcockDirector of the Center for Drug Evaluation and Research (CDER) atFood And Drug Administration (FDA)

bio2018-mybio-sessionicon-fireside

Fireside Chat with Christi Shaw, Senior Vice President and President, Lilly BIO-Medicines, Eli Lilly and Company

108A, Level 100

Erin McCallisterSenior Editor atBioCentury Christi ShawSenior Vice President and President atLilly BIO-Medicines, Eli Lilly and Company

bio2018-mybio-sessionicon-fireside

Fireside Chat with Dr. Norman Sharpless, Acting Commissioner, US Food and Drug Administration

109AB, Level 100

Cartier EshamExecutive Vice President, Emerging Companies atBiotechnology Innovation Organization (BIO) Norman SharplessActing Commissioner atUS Food & Drug Administration

bio2018-mybio-sessionicon-fireside

Fireside Chat with Jeffrey Solomon, Chief Executive Officer, COWEN

108A, Level 100

Jeremy Levin, BChir, MB, DPhilChairman & CEO atOvid Therapeutics Inc. Jeffrey SolomonChief Executive Officer atCOWEN

bio2018-mybio-sessionicon-fireside

Fireside Chat with Kenneth C. Frazier, Chairman of the Board and Chief Executive Officer, Merck & Co., Inc.

103ABC, Level 100

Ms. Meg TirrellReporter atCNBC Kenneth FrazierChairman of the Board and Chief Executive Officer atMerck & Co, Inc.

bio2018-mybio-sessionicon-fireside

Fireside Chat with Margaret (Peggy) Hamburg, MD, Foreign Secretary, National Academy of Medicine; Chairman of the Board, American Association for the Advancement of Science

115A, Level 100

Katrine BosleyChair, Emerging Companies Section atBIO Margaret HamburgForeign Secretary, National Academy of Medicine atChairman of the Board, American Association for the Advancement of Science

bio2018-mybio-sessionicon-fireside

Patient Advocacy

Understanding the Voices of Patients: Unique Perspectives on Healthcare

118B, Level 100

Julie GerberdingExecutive Vice President & Chief Patient Officer atMerck & Co, Inc. Christopher AnselmoMarket Intelligence Manager atMuscular Dystrophy Association Eve BukowskiVice President, Patient Advocacy, Education & Outreach atCalifornia Life Sciences Association (CLSA) Emily Kramer-GolinkoffCo-Founder atEmily's Entourage